Clinical Trial 45142

Kenosha, WI 53144


Summary:

The study is for a Nasal spray for acute treatment of migraines.

This clinical research study is testing the safety and effectiveness of a new investigational Nasal spray  in comparison to a placebo, to be used on an onset of migrane..

Qualified individuals will participate in a 11-week study period with approximately 3 in-person visits.

Approximately half the subjects in the study will receive placebo, meaning that you have a 50:50 chance of receiving placebo. The study treatment that you receive for the study will be selected at random, similar to flipping a coin.


Qualified Participants Must:

• Are 18 years old or older
• Have 2 -8 Migraines a month
• Migraine attacks present for more than 1 year, with age of onset prior to 50
• Able to comply with e-diary entries


Qualified Participants May Receive:

All study related care and study medication at no cost

Compensation for tiem and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.